Comparison of sampling methods for next generation sequencing for patients with lung cancer.
Kei KunimasaShingo MatsumotoKazumi NishinoKeiichiro HonmaNoboru MaedaHanako KuharaMotohiro TamiyaTakako InoueTakahisa KawamuraToru KimuraTomohiro ManiwaJiro OkamiKoichi GotoToru KumagaiPublished in: Cancer medicine (2022)
TBB is the mainstay of sampling methods, but for centrally located lesions, EBUS-TBNA may be a better strategy. For CT-guided biopsy, the success rate of RNA-based NGS analysis is low. Fluid samples are expected to yield successful results as surgical biopsy samples, but the latter are better for sample preservation. Determining the optimal method for genome biopsy for each case is important.